返回 Agenda
Session Chair(s)
Norbert Benda, PHD
Head of Biostatistics and Special Pharmacokinetics
Federal Institute For Drugs and Medical Devices (BfArM), Germany
Hans Ulrich Burger, PHD
Senior Director of Biostatistics
F. Hoffmann-La Roche Ltd., Switzerland
Speaker(s)
Overview on Issues in Developing New Therapies in Small Populations, Rare Diseases and Paediatric Indications
Kit B. Roes, PHD
University Medical Center Utrecht, Netherlands
Professor of Clinical Trial Methdology
20 Years of ICH E4 -Dose-Response / Dose-Finding Quo Vadis?
Andrew Peter Grieve, DRSC, PHD, MSC
Aptiv Solutions, Germany
Senior Vice President Clinical Trial Methodology
Statistical Analysis in Alzheimer’s Disease
David Brown, MSC
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Head of Statistics Team, Healthcare, Quality and Access